LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY
Clinical trials for LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY trials appear
Sign up with your email to follow new studies for LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy offers hope for kids with tough leukemia
Disease control Recruiting nowThis study tests a new combination of drugs for children and young adults whose leukemia or lymphoma has returned or not responded to treatment. The drugs include trametinib (a targeted therapy) plus standard chemotherapy. The goal is to find the safest dose and see if the combin…
Matched conditions: LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Jun 26, 2026 18:46 UTC
-
New cocktail of drugs hopes to beat childhood leukemia that Won't quit
Disease control Recruiting nowThis trial tests a combination of dasatinib, venetoclax, and chemotherapy in children and young adults with relapsed or refractory acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL). The study has two phases: first to find the safest dose, then to see how well it …
Matched conditions: LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Jun 26, 2026 17:34 UTC
-
New hope for kids with tough blood cancers: drug cocktail trial launches
Disease control Recruiting nowThis study tests a combination of two targeted drugs (ruxolitinib and venetoclax) plus standard chemotherapy in children and young adults up to age 21 whose leukemia or lymphoma has returned or not responded to treatment. The goal is to find the safest dose and see how many patie…
Matched conditions: LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Jun 26, 2026 17:34 UTC